Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-111601·ADC Therapeutics SA
Schedule 13G ownership disclosure
ADC THERAPEUTICS SA
Common Shares · CUSIP: H0036K147
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Prosight Management, LP
Shares: 7,195,374.00 · Class: 5.8%
- Prosight Fund, LP
Shares: 350,415.00 · Class: 0.3%
- Prosight Plus Fund, LP
Shares: 1,586,895.00 · Class: 1.3%
- Prosight Partners, LLC
Shares: 7,195,374.00 · Class: 5.8%
- W. Lawrence Hawkins
Shares: 7,195,374.00 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-111601
- Form type
- SCHEDULE 13G/A
- Filer
- ADC Therapeutics SA
- CIK
- CIK 1771910
- Filed
- Nov 13, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership